Mitsumi Terada (寺田 参省) , MD, PhD

Dr. TERADA’s story

Dr. Terada graduated with his MD from the Jikei University in 2009 and obtained PhD in 2019.
From 2011 to 2016, he worked as a surgeon for gastrointestinal cancer, especially for gastric cancer from 2014. He joined the EORTC in 2017 as a medical research fellow and learned methodology of international clinical trials on European basis. At the EORTC, he proposed and organized some collaborative projects and events between JCOG (Japan Clinical Oncology Group) and EORTC, which let him realize how important and significant the international collaboration is. He is also interested in PRO/QOL research for cancer patients and a chief investigator of an international collaborative study to update the EORTC QLQ STO22 that is QOL questionnaire for gastric cancer.
In 2019, he was mainly involved in the establishment of Asian Partnerships Office (APO) in Bangkok, Thailand under the ATLAS project and appointed General Manager of APO in September 2021. He resides in Bangkok from December 2021, and will contribute to development of the partnerships with multiple stakeholders and establishment of governance structure for the ATLAS network.

Research Interest

Clinical trial methodology, PRO/QOL research for cancer patinets

Professional Experience

Sep 2021-present	General Manager, Asian Partnerships Office, Department of International Clinical Development, NCCH, Japan
Jun 2019-present	Medical staff, International Trials Management Section, NCCH, Japan
Jun 2017-May 2019	Medical Research Fellow (Medical Department), EORTC HQ, and Clinical Research Fellow (International Trials Management Section), JCOG/NCCH Japan
Oct 2016-May 2017	Clinical Research Resident, Japan Clinical Oncology Group (JCOG)
Apr 2014-Sep 2016	Resident (Gastric surgery) National Cancer Center Hospital East, Chiba, Japan

• リンク